I' m thinking of buying into Pfe. What does Pfizer have in it's pipeline other than Viagra and the schizophrenic drug? Is it losing patent's on major drug's in the near future? Isn't the P/E ratio a high? Does Pfizer have a DRIP? If so, where do I call for this information. Serious reply's appreciated.Thanks in advance.
Norvasc is old news. Let's talk about Trovan, Zithromax (IV), Zeldox, and Viagra. PFE will have 4 newly FDA approved drugs by summer '98. To get 4 products approved in one year is outstanding. Not to mention the co-marketing agreement with WLA (lipitor) and MTC (Celebra). I sold my shares of LLY and bought PFE due to the incredible outlook of the company. I am very pleased so far. I don't think there will too much downside to the stock. As for a certain strategy, I would buy as much as possible on dips in stock price. The hospital in which I work uses incredible amounts of Trovan and Zithromax. It appears PFE has cornered the Quinolone and Macrolide market with these 2 antibiotics. If Viagra comes out with weak sales (eq. Evista from LLY), the stock will have downward pressure, or another great buying oppurtunity. I am a little surprised CSCO hasn't moved in price as LU. It seems as though LU is Wall Streets new "darling". See you on the CSCO board.